Cachexia Treatment Market Opportunity, CAGR 5.30%, Trend, Drivers, Restraint, Demand and Global Business Growth by 2029

Cachexia Treatment Market document helps disclose ambiguities that may happen due to changes in business activities or entry of a new product in the market. Under market definition topic of this report, market drivers which indicate the factors causing rise in the market growth and market restraints which indicate the factors causing fall in the market growth have been explored. The report also showcases important product developments and tracks recent acquisitions, mergers and research in the Healthcare industry by the key players of the market. Global Cachexia Treatment Marketing report not only works to compete but also to outshine the competition.

In recent years, the cachexia treatment market is anticipated to grow rapidly during the forecast period. According to the National Center for Biotechnology Information (NCBI), cancer cachexia affects half of all cancer patients, resulting in a gradual loss of adipose tissue and skeletal muscle mass. Cachexia syndrome has a significant influence on patient quality of life and poor reactions to therapies such as chemotherapy and a reduced probability of survival. Cachexia remains an underappreciated and neglected illness despite various processes implicated in its development. Treatments for cachexia include or exigenic appetite stimulants, which aim to alleviate symptoms and reduce patient misery.

Data Bridge Market Research analyses that the cachexia treatment market was valued at USD 1.88 billion in 2021 and is expected to reach USD 2.84 billion by 2029, registering a CAGR of 5.30% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-cachexia-treatment-market

Cachexia is a wasting disorder characterized by rapid weight loss, muscular wasting, and fat loss. People with HIV/AIDS, advanced cancer, chronic obstructive pulmonary disease (COPD), congestive heart failure and kidney illness are affected by this syndrome (CHF). The most frequent medications used to treat cachexia include appetite stimulants, anti-inflammatory medicines, corticosteroids, Enobosarm, and other anabolics.

Cachexia Treatment Market Dynamics

Drivers

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases such as cancer, diabetes, heart failure and others is estimated to enhance the cachexia treatment market's growth. The cachexia treatment market will expand due to the rising occurrence of cancer cachexia and the discovery of novel therapies for its treatment.

Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of cachexia treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Growing number of geriatric population

The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to get chronic ailments, further estimated to enhance the market's growth rate.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the cachexia treatment market. Additionally, advancements related to treatment of cancer cachexia and sedentary lifestyle of people will result in the expansion of cachexia treatment market.

Some of the major players operating in the cachexia treatment market are:

F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd.(Israel)
Sanofi (France), Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
AstraZeneca (UK)
Johnson & Johnson (US)
Bayer AG (Germany)
Sun Pharmaceutical Industries Ltd. (India)
Hikma Pharmaceuticals PLC (UK)
Lannett (US)
Akorn, Incorporated (US)
LEO Pharma A/S (Denmark)
Aurobindo Pharma (India)
Lupin (India)
Eli Lilly and Company (US)
Endo International plc (Ireland)
WOCKHARDT (India)

Recent Development

In April 2021, Helsinn announced the launch of adlumiz (anamorelin) to treat patients with cancer cachexia in Japan. Anamorelin is a ghrelin receptor agonist that is selective and orally active. The stomach produces ghrelin, which is an endogenous peptide. Ghrelin stimulates various pathways in the regulation of body weight, muscle mass, hunger, and metabolism once it binds to its receptor.

Global Cachexia Treatment Market Scope

The cachexia treatment market is segmented on the basis of drugs, indication, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs

Dronabinol
Mega Sterol Acetate
Corticosteroids
Others

Indication

Cancer
Congestive Heart Failure (CHF)
Rheumatoid Arthritis
Chronic Kidney Disease
Cystic Fibrosis
Chronic Obstructive Pulmonary disease (COPD)

Dosage form

Tablets
Injections
Others

Route of Administration

Oral
Parenteral
Others

End-Users

Hospitals
Specialty Clinics
Homecare
Others

Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

Some of the Most Important Questions Scrutinized in the Business Intelligence Report:

What are the key growth parameters for this global market during the forecast period?
Which key players are expected to hold the largest market share over the forecast period?
Who are the leading vendors and manufacturers in this  Cachexia Treatment Market ?
What are the key strategies adopted by leading players in the market for business development and geographical expansion?
Which end-use industries can trigger high demand in the market over the forecast period?
What are the key segments in this market?
Which regional player will have anticipated leading the global market in terms of size?
What is the impact of the novel coronavirus pandemic?
Which obstacles must new players overcome in order to occupy a major position?

Browse More Reports

https://markettreports.blogspot.com/2023/10/middle-east-and-africa-healthcare-it.html

https://markettreports.blogspot.com/2023/10/drug-screening-market-to-perceive.html

https://markettreports.blogspot.com/2023/10/std-diagnostics-market-to-receive.html

https://markettreports.blogspot.com/2023/10/digital-polymerase-chain-reaction-pcr.html

About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com

This release was published on openPR.